Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFR(CT)

AIMS: Icosapent ethyl (IPE) significantly reduced ischaemic events in statin-treated patients with atherosclerosis or diabetes and elevated triglycerides in REDUCE-IT, including large reductions in myocardial infarction and elective, urgent, and emergent coronary revascularization. However, the mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabbat, Mark G, Lakshmanan, Suvasini, Benjamin, Mina M, Doros, Gheorghe, Kinninger, April, Budoff, Matthew J, Bhatt, Deepak L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284047/
https://www.ncbi.nlm.nih.gov/pubmed/37082990
http://dx.doi.org/10.1093/ehjci/jead063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284047/
https://www.ncbi.nlm.nih.gov/pubmed/37082990
http://dx.doi.org/10.1093/ehjci/jead063

Ejemplares similares